Literature DB >> 22659249

Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN).

Ping G Tepper1, John F Randolph, Daniel S McConnell, Sybil L Crawford, Samar R El Khoudary, Hadine Joffe, Ellen B Gold, Huiyong Zheng, Joyce T Bromberger, Kim Sutton-Tyrrell.   

Abstract

CONTEXT: Variability in the pattern of change in estradiol (E2) and FSH levels over the menopause transition has not been well defined.
OBJECTIVE: The current study aimed to determine whether different trajectories of E2 and FSH could be identified and whether race/ethnicity and body mass index were related to the different trajectories.
DESIGN: The Study of Women's Health Across the Nation is a longitudinal observational study of the menopausal transition.
SETTING: Women aged 42-52 yr from seven participating sites were recruited and underwent up to 11 annual visits. PARTICIPANTS: Postmenopausal women with 12 or more months of amenorrhea that was not due to hysterectomy/oophorectomy and who were not using hormone therapy before the final menstrual period participated in the study. MAIN OUTCOME MEASURES: Annual serum E2 and FSH levels anchored to final menstrual period were measured.
RESULTS: Four distinct E2 trajectories and three distinct FSH trajectories were identified. The E2 trajectories were: slow decline (26.9%), flat (28.6%), rise/slow decline (13.1%), and rise/steep decline (31.5%). The FSH trajectories were: low (10.6%), medium (48.7%), and high (41.7%) rising patterns. Obesity increased the likelihood of a flat E2 and low FSH trajectory for all race/ethnic groups. Normal-weight Caucasian and African-American women tended to follow the rise/steep decline E2 and high FSH trajectories. Normal-weight Chinese/Japanese women tended to follow the slow decline E2 and the high/medium FSH trajectories.
CONCLUSIONS: E2 and FSH trajectories over the menopausal transition are not uniform across the population of women. Race/ethnicity and body mass index affect the trajectory of both E2 and FSH change over the menopausal transition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659249      PMCID: PMC3410268          DOI: 10.1210/jc.2012-1422

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

Review 1.  Menstrual cycle variability and the perimenopause.

Authors:  K A O'Connor; D J Holman; J W Wood
Journal:  Am J Hum Biol       Date:  2001 Jul-Aug       Impact factor: 1.937

2.  Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial/multiethnic, multisite study of women at midlife.

Authors:  MaryFran R Sowers; Angela L Wilson; Sharon R Kardia; Jian Chu; Robert Ferrell
Journal:  Am J Med       Date:  2006-09       Impact factor: 4.965

3.  Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in luteinizing hormone and follicle-stimulating hormone with age.

Authors:  Rebecca J Ferrell; Kathleen A O'Connor; Darryl J Holman; Eleanor Brindle; Rebecca C Miller; Germán Rodriguez; James A Simon; Phyllis K Mansfield; James W Wood; Maxine Weinstein
Journal:  Menopause       Date:  2007 Jan-Feb       Impact factor: 2.953

4.  Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status.

Authors:  John F Randolph; MaryFran Sowers; Ellen B Gold; Beth A Mohr; Judith Luborsky; Nanette Santoro; Daniel S McConnell; Joel S Finkelstein; Stanley G Korenman; Karen A Matthews; Barbara Sternfeld; Bill L Lasley
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

5.  Menstrual patterns leading to the final menstrual period.

Authors:  John R Taffe; Lorraine Dennerstein
Journal:  Menopause       Date:  2002 Jan-Feb       Impact factor: 2.953

6.  Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.

Authors:  John F Randolph; Huiyong Zheng; MaryFran R Sowers; Carolyn Crandall; Sybil Crawford; Ellen B Gold; Marike Vuga
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

7.  Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.

Authors:  Giovanni De Pergola; Simona Maldera; Massimo Tartagni; Nicola Pannacciulli; Giuseppe Loverro; Riccardo Giorgino
Journal:  Obesity (Silver Spring)       Date:  2006-11       Impact factor: 5.002

8.  Physical activity patterns in a diverse population of women.

Authors:  B Sternfeld; B E Ainsworth; C P Quesenberry
Journal:  Prev Med       Date:  1999-03       Impact factor: 4.018

9.  Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.

Authors:  John F Randolph; MaryFran Sowers; Irina V Bondarenko; Siobán D Harlow; Judith L Luborsky; Roderick J Little
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

Review 10.  Sources of estrogen and their importance.

Authors:  E R Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

View more
  49 in total

1.  TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women.

Authors:  Pascal Azar; José Enrique Mejía; Claire Cenac; Arnoo Shaiykova; Ali Youness; Sophie Laffont; Asma Essat; Jacques Izopet; Caroline Passaes; Michaela Müller-Trutwin; Pierre Delobel; Laurence Meyer; Jean-Charles Guéry
Journal:  JCI Insight       Date:  2020-06-18

2.  Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.

Authors:  Kara L Marlatt; Leanne M Redman; Robbie A Beyl; Steve R Smith; Catherine M Champagne; Fanchao Yi; Jennifer C Lovejoy
Journal:  Am J Obstet Gynecol       Date:  2019-10-11       Impact factor: 8.661

Review 3.  Management of the Perimenopause.

Authors:  Lara Delamater; Nanette Santoro
Journal:  Clin Obstet Gynecol       Date:  2018-09       Impact factor: 2.190

Review 4.  Cognitive Changes with Reproductive Aging, Perimenopause, and Menopause.

Authors:  Kelly N Morgan; Carol A Derby; Carey E Gleason
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

5.  Menopause, complement, and hemostatic markers in women at midlife: the Study of Women's Health Across the Nation.

Authors:  Samar R El Khoudary; Kelly J Shields; Hsiang-Yu Chen; Karen A Matthews
Journal:  Atherosclerosis       Date:  2013-09-05       Impact factor: 5.162

Review 6.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

7.  Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation.

Authors:  Amanda A Allshouse; Alex Polotsky; Sybil Crawford; Hsiang-Yu Chen; Samar R El Khoudary; Nanette Santoro
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

8.  Characterizing the trajectories of vasomotor symptoms across the menopausal transition.

Authors:  Ping G Tepper; Maria M Brooks; John F Randolph; Sybil L Crawford; Samar R El Khoudary; Ellen B Gold; Bill L Lasley; Bobby Jones; Hadine Joffe; Rachel Hess; Nancy E Avis; Sioban Harlow; Daniel S McConnell; Joyce T Bromberger; Huiyong Zheng; Kristine Ruppert; Rebecca C Thurston
Journal:  Menopause       Date:  2016-10       Impact factor: 2.953

Review 9.  Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.

Authors:  Jennifer L Gordon; Susan S Girdler; Samantha E Meltzer-Brody; Catherine S Stika; Rebecca C Thurston; Crystal T Clark; Beth A Prairie; Eydie Moses-Kolko; Hadine Joffe; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2015-01-13       Impact factor: 18.112

10.  Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Nanette Santoro; Hsiang-Yu Chen; Ping G Tepper; Maria M Brooks; Rebecca C Thurston; Imke Janssen; Sioban D Harlow; Emma Barinas-Mitchell; Faith Selzer; Carol A Derby; Elizabeth A Jackson; Daniel McConnell; Karen A Matthews
Journal:  Eur J Prev Cardiol       Date:  2015-09-18       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.